Table 3. Top 20 Significantly differentiated target Genes in lung cancer.
| Gene name | Training set | Testing set | ||||
|---|---|---|---|---|---|---|
| P-value | FC | FDR | P-value | FC | FDR | |
| KIAA1462 | 2.23E-45 | −3.41 | 1.72E-44 | 1.28E-20 | −3.26 | 9.84E-20 |
| MMD | 2.58E-41 | −4.46 | 2.17E-40 | 5.85E-16 | −3.11 | 9.36E-15 |
| CBX7 | 2.57E-33 | −2.11 | 2.34E-32 | 5.42E-23 | −2.19 | 1.19E-21 |
| FAP | 1.23E-27 | 3.07 | 9.47E-27 | 8.36E-15 | 3.01 | 1.08E-13 |
| GPM6A | 7.11E-61 | −7.49 | 5.98E-60 | 2.15E-23 | −4.40 | 1.66E-22 |
| FAM107A | 2.17E-46 | −6.39 | 1.67E-45 | 2.05E-21 | −3.16 | 1.87E-20 |
| SEMA6A | 3.49E-39 | −2.98 | 2.69E-38 | 8.42E-04 | −1.59 | 6.48E-03 |
| THBD | 1.91E-38 | −3.19 | 1.34E-37 | 5.89E-18 | −2.41 | 5.36E-17 |
| COL1A1 | 9.58E-37 | 3.06 | 8.72E-36 | 1.75E-05 | 2.33 | 1.05E-03 |
| STK39 | 1.24E-35 | 2.31 | 8.67E-35 | 3.62E-08 | 1.49 | 2.78E-07 |
| PDK4 | 8.50E-33 | −3.72 | 7.74E-32 | 3.36E-11 | −2.72 | 2.82E-10 |
| LIMCH1 | 1.49E-32 | −2.52 | 1.35E-31 | 8.04E-16 | −2.47 | 6.76E-15 |
| OLFML1 | 2.60E-30 | −2.60 | 2.18E-29 | 3.55E-18 | −2.56 | 2.73E-17 |
| TOX3 | 3.66E-26 | 3.93 | 3.07E-25 | 2.13E-09 | 3.50 | 1.79E-08 |
| GREM1 | 2.28E-24 | 6.76 | 1.75E-23 | 5.18E-05 | 2.06 | 3.99E-04 |
| SLC2A1 | 1.19E-23 | 2.56 | 8.32E-23 | 2.19E-06 | 1.76 | 1.61E-05 |
| TTK | 1.25E-23 | 3.19 | 9.66E-23 | 2.39E-11 | 2.61 | 2.17E-10 |
| OLR1 | 6.33E-20 | −3.22 | 5.76E-19 | 1.24E-07 | −2.07 | 1.13E-06 |
| SIX1 | 5.12E-18 | 2.46 | 3.59E-17 | 2.74E-08 | 2.03 | 2.11E-07 |
| IGF2BP3 | 2.04E-13 | 2.01 | 1.71E-12 | 9.76E-11 | 2.66 | 8.88E-10 |